Hepion Pharmaceuticals, Inc. announced the passing of Thomas Adams, Ph.D., a member of its Board of Directors. Dr. Adams died of natural causes on January 9, 2022. A seasoned biotechnology veteran, Dr. Adams was appointed to Hepion's Board in September 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | -10.85% | -12.21% | -64.51% |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Apr. 22 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.51% | 7.06M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- HEPA Stock
- News Hepion Pharmaceuticals, Inc.
- Hepion Pharmaceuticals, Inc Announces Demise of Thomas Adams, Ph.D., Member of Its Board of Directors